Real world outcomes of patients with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation after induction with liposomal daunorubicin-cytarabine (CPX-351).
Saved in:
| Title: | Real world outcomes of patients with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation after induction with liposomal daunorubicin-cytarabine (CPX-351). |
|---|---|
| Authors: | Ngo, Dat1 (AUTHOR), Kaleka, Guneet2 (AUTHOR), Yang, Dongyun3 (AUTHOR), Mokhtari, Sally3 (AUTHOR), Tinajero, Jose1 (AUTHOR), Marcucci, Guido4 (AUTHOR), Nakamura, Ryotaro4 (AUTHOR), Pullarkat, Vinod4 (AUTHOR), Oliai, Caspian2 (AUTHOR), Salhotra, Amandeep4 (AUTHOR) asalhotra@coh.org |
| Source: | Leukemia & Lymphoma. Feb2026, Vol. 67 Issue 3, p718-721. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10428194 |
|---|---|
| DOI: | 10.1080/10428194.2025.2584682 |
